Insider Trading Alert - MED, IPG And LEG Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, June 15, 2015, 81 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $428.00 to $1,771,500.00.

Highlighted Stocks Traded by Insiders:

Medifast (MED) - FREE Research Report

Bondroff Barry B, who is Director at Medifast, sold 1,666 shares at $31.88 on June 15, 2015. Following this transaction, the Director owned 14,533 shares meaning that the stake was reduced by 10.28% with the 1,666-share transaction.

The shares most recently traded at $32.43, up $0.55, or 1.7% since the insider transaction. Historical insider transactions for Medifast go as follows:

  • 4-Week # shares sold: 22,050
  • 12-Week # shares sold: 22,050
  • 24-Week # shares sold: 22,050

The average volume for Medifast has been 104,900 shares per day over the past 30 days. Medifast has a market cap of $394.3 million and is part of the services sector and specialty retail industry. Shares are down 3.28% year-to-date as of the close of trading on Monday.

Medifast, Inc. engages in the production, distribution, and sale of weight loss and weight management products and other consumable health and diet products. The company has a P/E ratio of 21.4. Currently, there are no analysts who rate Medifast a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MED - FREE

TheStreet Quant Ratings rates Medifast as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and expanding profit margins. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full Medifast Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Interpublic Group of Companies (IPG) - FREE Research Report

Miller Henry S, who is Director at Interpublic Group of Companies, bought 5,000 shares at $20.12 on June 15, 2015. Following this transaction, the Director owned 12,175 shares meaning that the stake was boosted by 69.69% with the 5,000-share transaction.

The shares most recently traded at $20.02, down $0.10, or 0.49% since the insider transaction. Historical insider transactions for Interpublic Group of Companies go as follows:

  • 4-Week # shares sold: 11,042
  • 12-Week # shares sold: 11,042
  • 24-Week # shares sold: 241,465

The average volume for Interpublic Group of Companies has been 3.4 million shares per day over the past 30 days. Interpublic Group of Companies has a market cap of $8.3 billion and is part of the services sector and media industry. Shares are down 4.24% year-to-date as of the close of trading on Monday.

The Interpublic Group of Companies, Inc. provides advertising and marketing services. The company operates in two segments, Integrated Agency Networks and Constituency Management Group. The stock currently has a dividend yield of 2.4%. The company has a P/E ratio of 17.1. Currently, there are 7 analysts who rate Interpublic Group of Companies a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IPG - FREE

TheStreet Quant Ratings rates Interpublic Group of Companies as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, notable return on equity, attractive valuation levels and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full Interpublic Group of Companies Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Leggett & Platt (LEG) - FREE Research Report

DeSonier David M, who is SVP-Strategy&InvestorRelations at Leggett & Platt, sold 10,000 shares at $49.01 on June 15, 2015. Following this transaction, the SVP-Strategy&InvestorRelations owned 59,222 shares meaning that the stake was reduced by 14.45% with the 10,000-share transaction.

The shares most recently traded at $48.21, down $0.80, or 1.67% since the insider transaction. Historical insider transactions for Leggett & Platt go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 14,987
  • 24-Week # shares sold: 59,301

The average volume for Leggett & Platt has been 947,600 shares per day over the past 30 days. Leggett & Platt has a market cap of $6.7 billion and is part of the consumer goods sector and consumer durables industry. Shares are up 13.1% year-to-date as of the close of trading on Monday.

Leggett & Platt, Incorporated designs and produces a range of engineered components and products worldwide. The stock currently has a dividend yield of 2.54%. The company has a P/E ratio of 29.1. Currently, there are no analysts who rate Leggett & Platt a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LEG - FREE

TheStreet Quant Ratings rates Leggett & Platt as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, notable return on equity, good cash flow from operations and solid stock price performance. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Leggett & Platt Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists